Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated just now
Peer-reviewedCC BY-NCBiomaterials Science

A 3D pancreatic tumor model to study T cell infiltration

Abstract

3D PDAC-TME model to observe and quantify T cell infiltration across the vasculature. In a three-channel microfluidic device, PDAC cells are cultured in a collagen matrix in the central channel surrounded, on one side, by endothelial cells (ECs) to mimic a blood vessel and, on the opposite side, by pancreatic stellate cells (PSCs) to simulate exocrine pancreas. The migration of T cells toward the tumor is quantified based on their activation state and TME composition. The presence of EC-lining drastically reduces T cell infiltration, confirming the essential role of the vasculature in controlling T cell trafficking. We show that activated T cells migrate ∼50% more than the not-activated ones toward the cancer cells. Correspondingly, in the absence of cancer cells, both activated and not-activated T cells present similar migration toward the PSCs. The proposed approach could help researchers in testing and optimizing immunotherapies for pancreatic cancer.

Related

  1. Fast receptor-antigen dissociation kinetics promote CAR-T cell tumor infiltration, functional fitness, and antitumor efficacy in solid tumors
    R. Mao, H. Shi, M. S. Hussein +6
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  2. Whole-genome sequencing reveals tumor T-cell infiltration associated with immunotherapy outcomes
    J. L. Usset, H. W. Lee, R. Jones +4
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  3. Immune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies
    Gangzhao Gu, Yang Du, Hengzhi Zhang +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  4. Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression
    Christophe Quemerais, Christine Jean, Alexia Brunel +14
    Cancer LettersPeer-reviewedCC BY6 citedCell biologyOncologyHAL
  5. Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment
    Giulio Giustarini, Germaine Teng, Andrea Pavesi +1
    Frontiers in OncologyPeer-reviewedCC BYFull text25 citedGeneral biologyOncologyHAL
BibTeX
@article{mollica2026pancreatic,
  title = {{A 3D pancreatic tumor model to study T cell infiltration}},
  author = {Hilaria Mollica and Yi Juan Teo and Alrina Shin Min Tan and Damien Zhi Ming Tan and Paolo Decuzzi and Andrea Pavesi and Giulia Adriani},
  journal = {Biomaterials Science},
  year = {2026},
  month = oct,
  doi = {10.1039/d1bm00210d},
  url = {https://hal.science/hal-05776435v1},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - A 3D pancreatic tumor model to study T cell infiltration
AU  - Hilaria Mollica
AU  - Yi Juan Teo
AU  - Alrina Shin Min Tan
AU  - Damien Zhi Ming Tan
AU  - Paolo Decuzzi
AU  - Andrea Pavesi
AU  - Giulia Adriani
PY  - 2026
DA  - 2026/10/03
JO  - Biomaterials Science
DO  - 10.1039/d1bm00210d
UR  - https://hal.science/hal-05776435v1
AB  - 3D PDAC-TME model to observe and quantify T cell infiltration across the vasculature. In a three-channel microfluidic device, PDAC cells are cultured in a collagen matrix in the central channel surrounded, on one side, by endothelial cells (ECs) to mimic a blood vessel and, on the opposite side, by pancreatic stellate cells (PSCs) to simulate exocrine pancreas. The migration of T cells toward the tumor is quantified based on their activation state and TME composition. The presence of EC-lining drastically reduces T cell infiltration, confirming the essential role of the vasculature in controlling T cell trafficking. We show that activated T cells migrate ∼50% more than the not-activated ones toward the cancer cells. Correspondingly, in the absence of cancer cells, both activated and not-activated T cells present similar migration toward the PSCs. The proposed approach could help researchers in testing and optimizing immunotherapies for pancreatic cancer.
SN  - 2047-4830
ER  -